img

Global Monkeypox Therapeutics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Monkeypox Therapeutics Market Research Report 2024

According to MRAResearch’s new survey, global Monkeypox Therapeutics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monkeypox Therapeutics market research.
Key companies engaged in the Monkeypox Therapeutics industry include Chimerix Inc., SIGA Technologies, Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Hetero Drugs Limited, Mylan N.V., Piramal Enterprises Limited, Olon S.p.A. and Teva Pharmaceutical Industries Limited, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Monkeypox Therapeutics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Monkeypox Therapeutics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Monkeypox Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Chimerix Inc.
SIGA Technologies, Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
Segment by Type
Smallpox Vaccine
Antivirals
Vaccinia Immune Globulin (VIG)

Segment by Application


Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monkeypox Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Smallpox Vaccine
1.2.3 Antivirals
1.2.4 Vaccinia Immune Globulin (VIG)
1.3 Market by Application
1.3.1 Global Monkeypox Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Therapeutics Market Perspective (2018-2033)
2.2 Monkeypox Therapeutics Growth Trends by Region
2.2.1 Global Monkeypox Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Monkeypox Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Monkeypox Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Monkeypox Therapeutics Market Dynamics
2.3.1 Monkeypox Therapeutics Industry Trends
2.3.2 Monkeypox Therapeutics Market Drivers
2.3.3 Monkeypox Therapeutics Market Challenges
2.3.4 Monkeypox Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Therapeutics Players by Revenue
3.1.1 Global Top Monkeypox Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Monkeypox Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Monkeypox Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monkeypox Therapeutics Revenue
3.4 Global Monkeypox Therapeutics Market Concentration Ratio
3.4.1 Global Monkeypox Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Therapeutics Revenue in 2022
3.5 Monkeypox Therapeutics Key Players Head office and Area Served
3.6 Key Players Monkeypox Therapeutics Product Solution and Service
3.7 Date of Enter into Monkeypox Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Therapeutics Breakdown Data by Type
4.1 Global Monkeypox Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Monkeypox Therapeutics Forecasted Market Size by Type (2024-2033)
5 Monkeypox Therapeutics Breakdown Data by Application
5.1 Global Monkeypox Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Monkeypox Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Monkeypox Therapeutics Market Size (2018-2033)
6.2 North America Monkeypox Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Monkeypox Therapeutics Market Size by Country (2018-2023)
6.4 North America Monkeypox Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Therapeutics Market Size (2018-2033)
7.2 Europe Monkeypox Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Monkeypox Therapeutics Market Size by Country (2018-2023)
7.4 Europe Monkeypox Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Monkeypox Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Monkeypox Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Monkeypox Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Therapeutics Market Size (2018-2033)
9.2 Latin America Monkeypox Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Monkeypox Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Monkeypox Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Monkeypox Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Monkeypox Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Monkeypox Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chimerix Inc.
11.1.1 Chimerix Inc. Company Detail
11.1.2 Chimerix Inc. Business Overview
11.1.3 Chimerix Inc. Monkeypox Therapeutics Introduction
11.1.4 Chimerix Inc. Revenue in Monkeypox Therapeutics Business (2018-2023)
11.1.5 Chimerix Inc. Recent Development
11.2 SIGA Technologies, Inc.
11.2.1 SIGA Technologies, Inc. Company Detail
11.2.2 SIGA Technologies, Inc. Business Overview
11.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Introduction
11.2.4 SIGA Technologies, Inc. Revenue in Monkeypox Therapeutics Business (2018-2023)
11.2.5 SIGA Technologies, Inc. Recent Development
11.3 Emergent BioSolutions Inc.
11.3.1 Emergent BioSolutions Inc. Company Detail
11.3.2 Emergent BioSolutions Inc. Business Overview
11.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Introduction
11.3.4 Emergent BioSolutions Inc. Revenue in Monkeypox Therapeutics Business (2018-2023)
11.3.5 Emergent BioSolutions Inc. Recent Development
11.4 Bavarian Nordic A/S
11.4.1 Bavarian Nordic A/S Company Detail
11.4.2 Bavarian Nordic A/S Business Overview
11.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Introduction
11.4.4 Bavarian Nordic A/S Revenue in Monkeypox Therapeutics Business (2018-2023)
11.4.5 Bavarian Nordic A/S Recent Development
11.5 Hetero Drugs Limited
11.5.1 Hetero Drugs Limited Company Detail
11.5.2 Hetero Drugs Limited Business Overview
11.5.3 Hetero Drugs Limited Monkeypox Therapeutics Introduction
11.5.4 Hetero Drugs Limited Revenue in Monkeypox Therapeutics Business (2018-2023)
11.5.5 Hetero Drugs Limited Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Detail
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Monkeypox Therapeutics Introduction
11.6.4 Mylan N.V. Revenue in Monkeypox Therapeutics Business (2018-2023)
11.6.5 Mylan N.V. Recent Development
11.7 Piramal Enterprises Limited
11.7.1 Piramal Enterprises Limited Company Detail
11.7.2 Piramal Enterprises Limited Business Overview
11.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Introduction
11.7.4 Piramal Enterprises Limited Revenue in Monkeypox Therapeutics Business (2018-2023)
11.7.5 Piramal Enterprises Limited Recent Development
11.8 Olon S.p.A.
11.8.1 Olon S.p.A. Company Detail
11.8.2 Olon S.p.A. Business Overview
11.8.3 Olon S.p.A. Monkeypox Therapeutics Introduction
11.8.4 Olon S.p.A. Revenue in Monkeypox Therapeutics Business (2018-2023)
11.8.5 Olon S.p.A. Recent Development
11.9 Teva Pharmaceutical Industries Limited
11.9.1 Teva Pharmaceutical Industries Limited Company Detail
11.9.2 Teva Pharmaceutical Industries Limited Business Overview
11.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Introduction
11.9.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Therapeutics Business (2018-2023)
11.9.5 Teva Pharmaceutical Industries Limited Recent Development
11.10 CIDIC Company Limited
11.10.1 CIDIC Company Limited Company Detail
11.10.2 CIDIC Company Limited Business Overview
11.10.3 CIDIC Company Limited Monkeypox Therapeutics Introduction
11.10.4 CIDIC Company Limited Revenue in Monkeypox Therapeutics Business (2018-2023)
11.10.5 CIDIC Company Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Monkeypox Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Smallpox Vaccine
Table 3. Key Players of Antivirals
Table 4. Key Players of Vaccinia Immune Globulin (VIG)
Table 5. Global Monkeypox Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Monkeypox Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Monkeypox Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Monkeypox Therapeutics Market Share by Region (2018-2023)
Table 9. Global Monkeypox Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Monkeypox Therapeutics Market Share by Region (2024-2033)
Table 11. Monkeypox Therapeutics Market Trends
Table 12. Monkeypox Therapeutics Market Drivers
Table 13. Monkeypox Therapeutics Market Challenges
Table 14. Monkeypox Therapeutics Market Restraints
Table 15. Global Monkeypox Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Monkeypox Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Monkeypox Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Therapeutics as of 2022)
Table 18. Ranking of Global Top Monkeypox Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Monkeypox Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Monkeypox Therapeutics Product Solution and Service
Table 22. Date of Enter into Monkeypox Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Monkeypox Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Monkeypox Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Monkeypox Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Monkeypox Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Monkeypox Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Monkeypox Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Monkeypox Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Monkeypox Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Monkeypox Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Monkeypox Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Monkeypox Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Monkeypox Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Monkeypox Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Monkeypox Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Monkeypox Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Monkeypox Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Monkeypox Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Monkeypox Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Monkeypox Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Monkeypox Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Chimerix Inc. Company Detail
Table 48. Chimerix Inc. Business Overview
Table 49. Chimerix Inc. Monkeypox Therapeutics Product
Table 50. Chimerix Inc. Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Chimerix Inc. Recent Development
Table 52. SIGA Technologies, Inc. Company Detail
Table 53. SIGA Technologies, Inc. Business Overview
Table 54. SIGA Technologies, Inc. Monkeypox Therapeutics Product
Table 55. SIGA Technologies, Inc. Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 56. SIGA Technologies, Inc. Recent Development
Table 57. Emergent BioSolutions Inc. Company Detail
Table 58. Emergent BioSolutions Inc. Business Overview
Table 59. Emergent BioSolutions Inc. Monkeypox Therapeutics Product
Table 60. Emergent BioSolutions Inc. Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 61. Emergent BioSolutions Inc. Recent Development
Table 62. Bavarian Nordic A/S Company Detail
Table 63. Bavarian Nordic A/S Business Overview
Table 64. Bavarian Nordic A/S Monkeypox Therapeutics Product
Table 65. Bavarian Nordic A/S Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Bavarian Nordic A/S Recent Development
Table 67. Hetero Drugs Limited Company Detail
Table 68. Hetero Drugs Limited Business Overview
Table 69. Hetero Drugs Limited Monkeypox Therapeutics Product
Table 70. Hetero Drugs Limited Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Hetero Drugs Limited Recent Development
Table 72. Mylan N.V. Company Detail
Table 73. Mylan N.V. Business Overview
Table 74. Mylan N.V. Monkeypox Therapeutics Product
Table 75. Mylan N.V. Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Mylan N.V. Recent Development
Table 77. Piramal Enterprises Limited Company Detail
Table 78. Piramal Enterprises Limited Business Overview
Table 79. Piramal Enterprises Limited Monkeypox Therapeutics Product
Table 80. Piramal Enterprises Limited Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Piramal Enterprises Limited Recent Development
Table 82. Olon S.p.A. Company Detail
Table 83. Olon S.p.A. Business Overview
Table 84. Olon S.p.A. Monkeypox Therapeutics Product
Table 85. Olon S.p.A. Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Olon S.p.A. Recent Development
Table 87. Teva Pharmaceutical Industries Limited Company Detail
Table 88. Teva Pharmaceutical Industries Limited Business Overview
Table 89. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product
Table 90. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Teva Pharmaceutical Industries Limited Recent Development
Table 92. CIDIC Company Limited Company Detail
Table 93. CIDIC Company Limited Business Overview
Table 94. CIDIC Company Limited Monkeypox Therapeutics Product
Table 95. CIDIC Company Limited Revenue in Monkeypox Therapeutics Business (2018-2023) & (US$ Million)
Table 96. CIDIC Company Limited Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monkeypox Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Monkeypox Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Smallpox Vaccine Features
Figure 4. Antivirals Features
Figure 5. Vaccinia Immune Globulin (VIG) Features
Figure 6. Global Monkeypox Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Monkeypox Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Monkeypox Therapeutics Report Years Considered
Figure 13. Global Monkeypox Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Monkeypox Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Monkeypox Therapeutics Market Share by Region: 2022 VS 2033
Figure 16. Global Monkeypox Therapeutics Market Share by Players in 2022
Figure 17. Global Top Monkeypox Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Monkeypox Therapeutics Revenue in 2022
Figure 19. North America Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Monkeypox Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Monkeypox Therapeutics Market Share by Country (2018-2033)
Figure 25. Germany Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Monkeypox Therapeutics Market Share by Region (2018-2033)
Figure 33. China Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Monkeypox Therapeutics Market Share by Country (2018-2033)
Figure 41. Mexico Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Monkeypox Therapeutics Market Share by Country (2018-2033)
Figure 45. Turkey Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Monkeypox Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Chimerix Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 48. SIGA Technologies, Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 49. Emergent BioSolutions Inc. Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 50. Bavarian Nordic A/S Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 51. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 52. Mylan N.V. Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 53. Piramal Enterprises Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 54. Olon S.p.A. Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 55. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 56. CIDIC Company Limited Revenue Growth Rate in Monkeypox Therapeutics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed